Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions

BMC Family Practice

Volumn 15, Issue 1, 2014, Pages

  Rose, Peter W ^a   Hamilton, Willie ^b   Aldersey, Kate ^c   Barisic, Andriana ^d   Dawes, Martin ^e   Foot, Catherine ^f   Grunfeld, Eva ^g,h   Hart, Nigel ⁱ   Neal, Richard D ^j   Pirotta, Marie ^k   Sisler, Jeffrey ^l   Thulesius, Hans ^m   Vedsted, Peter ⁿ   Young, Jane ^o   Rubin, Greg ^p  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d Department of Prevention and Cancer Control Cancer Care Ontario ^*  (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f KING S FUND   (United Kingdom)

^g ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^j BANGOR UNIVERSITY   (United Kingdom)

^k Primary Health Care Research Evaluation and Development Department of General Practice   (Australia)

^l UNIVERSITY OF MANITOBA   (Canada)

^m LUND UNIVERSITY   (Sweden)

ⁿ AARHUS UNIVERSITY   (Denmark)

^o UNIVERSITY OF SYDNEY   (Australia)

^p DURHAM UNIVERSITY   (United Kingdom)

more..

Author keywords

Cancer; Diagnosis; International; Primary care; Survey

Indexed keywords

AUSTRALIA; CANADA; CLINICAL PRACTICE; DENMARK; HUMAN; NEOPLASMS; NORWAY; PRIMARY HEALTH CARE; QUESTIONNAIRE; STANDARDS; STATISTICS AND NUMERICAL DATA; SWEDEN; TRANSLATING (LANGUAGE); UNITED KINGDOM; VALIDATION STUDY;

AUSTRALIA; CANADA; DENMARK; ENGLAND; HUMANS; NEOPLASMS; NORWAY; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; QUESTIONNAIRES; SWEDEN; TRANSLATING;

EID: 84902301179     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-15-122     Document Type: Article

References (24)

1. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjersorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA, the ICBP Module 1 Working Group, Lancet 2010 377 127 138
2. The International Cancer Benchmarking Partnership: An international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom. Butler J, Foot C, Bomb M, Hiom S, Coleman M, Bryant H, Vedsted P, Hanson J, Richards M, Health Policy 2013 S112 1-2 148 155
3. Do diagnostic delays in cancer matter? Neal RD, Br J Cancer 2009 101 Suppl 2 9 S12 doi:10.1038/sj.bjc.6605384
4. Influence of delay on survival in patients with breast cancer: a systematic review. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ, Lancet 1999 353 9159 1119 1126 (Pubitemid 29155203)
5. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: A cohort study in primary care. Tørring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P, Eur J Cancer 2013 doi:10.1016/j.ejca.2013.01.025 (PMID: 23453935)
6. The Aarhus statement: Improving design and reporting of studies on early cancer diagnosis. Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Muth C, Beyer M, Neal RD, Br J Cancer 2012 106 7 1262 1267
7. Are the serious problems in cancer survival partly rooted in gatekeeper principles? An ecologic study. Vedsted P, Olesen F, Br J Gen Pract 2011 61 589 508 e512 doi:10.3399/bjgp11X588484
8. Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ, Br J Cancer 2009 101 Suppl 2 92 S101 doi:10.1038/sj.bjc.6605398
9. Less haste more speed: factors that prolong the interval from presentation to diagnosis in some cancers. Jiwa M, Reid J, Handley C, Grimwood J, Ward S, Turner K, Ibbotson M, Thorman N, Fam Pract 2004 21 3 299 303 (Pubitemid 38765306)
10. Delay in diagnosis of lung cancer in general practice. Bjerager M, Palshof T, Dahl R, Vedsted P, Olesen F, Br J Gen Pract 2006 56 532 863 868 (Pubitemid 44725415)
11. Cancer in Primary Care: An analysis of significant event audits (SEA) for diagnosis of lung cancer and cancers in teenagers and young adults 2008-9. Mitchell E, Macleod U, Rubin G, Report for the National Awareness and Early Diagnosis Initiative University of Dundee, University of Glasgow and University of Durham 2009 https://www.dur.ac.uk/resources/school.health/ AnalysisofSEAforcancerdiagnosis-Updatedfinalreport.pdf
12. Influences on prehospital delay in the diagnosis of colorectal cancer: a systematic review. Mitchell E, Macdonald S, Campbell NC, Weller D, Macleod U, Br J Cancer 2008 98 1 60 70
13. Pathways to the diagnosis of colorectal cancer: an observational study in three UK cities. Barrett J, Jiwa M, Rose P, Hamilton W, Fam Pract 2006 23 1 15 19
14. Minimizing delays in ovarian cancer diagnosis: an expansion of Andersen's model of "total patient delay. Evans J, Ziebland S, McPherson A, Fam Pract 2007 24 1 48 55 (Pubitemid 46454665)
15. Practical tips for surgical research: Research designs, hypotheses and objectives. Farrugia P, Petrisor BA, Farrakhyar F, Bhandari M, Can J Surg 2010 53 278 281
16. Clinical vignette-based surveys: a tool for assessing physician practice variation. Veloski J, Tai S, Evans AS, Nash DB, Am J Med Qual 2005 20 3 151 157 (Pubitemid 40880390)
17. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M, JAMA 2000 283 13 1715 1722 (Pubitemid 30196212)
18. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Peabody JW, Luck J, Glassman P, Jain S, Hansen J, Spell M, Lee M, Ann Intern Med 2004 141 10 771 780
19. What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Hamilton W, Peters TJ, Round A, Sharp D, Thorax 2005 60 12 1059 1065 (Pubitemid 41705477)
20. Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Hamilton W, Round A, Sharp D, Peters TJ, Br J Cancer 2005 93 4 399 405 (Pubitemid 43080012)
21. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. Hamilton W, Peters TJ, Bankhead C, Sharp D, BMJ 2009 339 2998 doi:10.1136/bmj.b2998
22. Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. Jones R, Charlton J, Latinovic R, Gulliford MC, BMJ 2009 339 3094 doi:10.1136/bmj.b3094
23. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. Guillemin F, Bombardier C, Beaton D, J Clin Epidemiol 1993 46 12 1417 1432 (Pubitemid 24017263)
24. Interpreting trends in cancer patient survival. Dickman P, Adami H-O, J Intern Med 2006 260 103 117 (Pubitemid 44051335)